[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"low-dose\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:low-dose":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100587473","role-of-low-dose-injectable-progesterone-in-triggering-ovulation-100587473",false,"NCT06928844","Role of Low Dose Injectable Progesterone in Triggering Ovulation","Role of Low Dose Injectable Progesterone in Triggering Ovulation: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Age from 20 to 35 years.\n* Infertile women.\n* Basal follicle-stimulating hormone (FSH) level \\\u003C10 mIU\u002Fml.\n\nExclusion Criteria:\n\n* Poor ovarian reserve.\n* Immunological disease.\n* Endometriosis.\n* Uterine abnormality.\n* Body mass index (BMI) \\>30 kg\u002Fm2.\n* Endometrial thickness \\\u003C8 or \\>12 mm on the day of triggering.","FEMALE","20 Years","35 Years",{"count":20,"type":21},120,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.",[27,28,29],"Low Dose","Progesterone","Triggering Ovulation","RECRUITING","2025-04-15",{"date":33,"type":34},"2025-04-16","ACTUAL",{"date":31,"type":34},{"date":37,"type":21},"2025-08-01",{"name":39,"class":40},"The General Authority for Teaching Hospitals and Institutes","NETWORK"]